EUROCARE-5 delivered the good news that survival rates have been increasing across Europe. In this editorial we ask: how much of this improvement is the result of the widespread increase in per capita health spending [more]
Phase I trials now play an essential role in treating patients with metastatic cancer, offering vital extra moves in the battle to outplay the disease, says Jean-Charles Soria. He warns, however, that not every patient [more]
Better understanding of the impact that treating pregnant women for cancer has on their unborn child means women in this position have more options open to them, as Ainhoa Iriberri explains in this article, which [more]
The complexity of cancer, the risks and benefits associated with alternative treatment options, the care needs of patients, all point to the need for input from specialists in many disciplines. But are regular face-to-face multidisciplinary [more]
Thrombosis is the second most common preventable cause of death in patients with cancer, so oncologists need to know how to identify who is at risk, and strategies for prevention and treatment. This overview presents [more]
The ABC conference on advanced breast cancer gives centre stage to a group of patients who feel theyve been marginalised and their needs ignored for too long. People who have been treated for early-stage breast [more]
Every summer a group of top oncologists gather in the ancient city of Ioannina to give a select group of motivated medical students a taste of what its like to work in cancer. The number [more]
By the time they reach 40, survivors of childhood cancers are likely to have at least one chronic health problem resulting from their treatment. The search is now on for ways to help people manage [more]
As we learn more about what lies behind the differences in cancer outcomes across Europe, the question becomes: how do we end them? This article was first published in The Oncologist vol.18 no.12, and is [more]
Concerns still exist regarding the best use of low-dose CT screening for lung cancer and how to select high-risk individuals who will benefit most from participation in screening programmes. Two studies now indicate factors that [more]